MiniMed (MMED) Receivables (2025 - 2026)

MiniMed (MMED) posted Receivables of $782.0 million for Q3 2026, up 19.39% quarter-over-quarter from $655.0 million in Q2 2026.

Analysis

MiniMed (MMED) Receivables (2025 - 2026) Analysis & Trends

MiniMed (MMED) has 2 years of Receivables data on file, last reported at $782.0 million in Q3 2026.

For the quarter ending Q3 2026, Receivables changed N/A year-over-year to $782.0 million; the trailing twelve-month figure through Jul 2026 stood at $782.0 million (changed N/A YoY), and the FY2026 full-year result was $655.0 million, up 14.91% from the prior year.
Receivables was $782.0 million for Q3 2026 at MiniMed, up from $655.0 million in the prior quarter.
In the past five years, Receivables ranged from a high of $782.0 million in Q3 2026 to a low of $570.0 million in Q2 2025.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Receivables (Qtr)
1	Abbott Laboratories	183.04 Bn	177.44 Bn	7.27 Bn	8.60 Bn
2	Intuitive Surgical	125.02 Bn	119.81 Bn	1.96 Bn	1.67 Bn
3	Medtronic	117.84 Bn	109.02 Bn	6.34 Bn	6.36 Bn
4	Stryker	105.50 Bn	102.02 Bn	4.50 Bn	3.74 Bn
5	Boston Scientific	66.27 Bn	65.73 Bn	3.85 Bn	3.18 Bn
6	Edwards Lifesciences	49.60 Bn	45.35 Bn	1.35 Bn	955.70 Mn
7	Alcon	33.70 Bn	32.24 Bn	1.68 Bn	2.08 Bn
8	Dexcom	32.06 Bn	30.11 Bn	830.00 Mn	1.28 Bn
9	Steris	21.02 Bn	20.54 Bn	684.20 Mn	1.01 Bn
10	MiniMed	6.37 Bn	6.17 Bn	465.00 Mn	782.00 Mn

Historic Data

Download Data